Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Head and Neck Cancer

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 110 articles:
HTML format
Text format



Single Articles


    March 2019
  1. YE F, Gao H, Xiao L, Ding H, et al
    Reply to Cirello et al. "Absence of the MAP2K5 germline variants c.G961A and c. T1100C in a wide series of familial non-medullary thyroid carcinoma Italian families." International Journal of Cancer 2019; in press.
    Int J Cancer. 2019 Mar 3. doi: 10.1002/ijc.32243.
    PubMed     Text format    


  2. CIRELLO V, Colombo C, Persani L, Fugazzola L, et al
    Absence of the MAP2K5 germline variants c.G961A and c.T1100C in a wide series of familial non-medullary thyroid carcinoma Italian families.
    Int J Cancer. 2019 Mar 3. doi: 10.1002/ijc.32244.
    PubMed     Text format    


    January 2019
  3. TAN GW, Sivanesan VM, Abdul Rahman FI, Hassan F, et al
    A novel and non-invasive approach utilising nasal washings for the detection of nasopharyngeal carcinoma.
    Int J Cancer. 2019 Jan 30. doi: 10.1002/ijc.32173.
    PubMed     Text format     Abstract available


  4. NOVOPLANSKY O, Fury M, Prasad M, Yegodayev K, et al
    MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer.
    Int J Cancer. 2019 Jan 29. doi: 10.1002/ijc.32170.
    PubMed     Text format     Abstract available


  5. KAWAKITA D, Lee YA, Gren LH, Buys SS, et al
    Fiber Intake and the Risk of Head and Neck Cancer in the prostate, lung, colorectal, and ovarian (PLCO) cohort.
    Int J Cancer. 2019 Jan 29. doi: 10.1002/ijc.32162.
    PubMed     Text format     Abstract available


  6. LI WF, Chen NY, Zhang N, Hu GQ, et al
    Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial.
    Int J Cancer. 2019 Jan 6. doi: 10.1002/ijc.32099.
    PubMed     Text format     Abstract available


    December 2018
  7. MENYA D, Maina SK, Kibosia C, Kigen N, et al
    Dental fluorosis and oral health in the African Esophageal Cancer Corridor: Findings from the Kenya ESCCAPE case-control study and a pan-African perspective.
    Int J Cancer. 2018 Dec 23. doi: 10.1002/ijc.32086.
    PubMed     Text format     Abstract available


  8. GRABER JM, Harris G, Black K, Lucchini RG, et al
    Excess HPV-related head and neck cancer in the World Trade Center Health Program General Responder cohort.
    Int J Cancer. 2018 Dec 17. doi: 10.1002/ijc.32070.
    PubMed     Text format     Abstract available


  9. HUI KF, Chan TF, Yang W, Shen JJ, et al
    High risk Epstein-Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma.
    Int J Cancer. 2018 Dec 10. doi: 10.1002/ijc.32049.
    PubMed     Text format     Abstract available


    November 2018
  10. MATOBA T, Imai M, Ohkura N, Kawakita D, et al
    Regulatory T cells expressing abundant CTLA-4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer.
    Int J Cancer. 2018 Nov 28. doi: 10.1002/ijc.32024.
    PubMed     Text format     Abstract available


  11. ZHANG Y, Tang LL, Li YQ, Liu X, et al
    Spontaneous remission of residual post-therapy plasma Epstein-Barr virus DNA and its prognostic implication in nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis.
    Int J Cancer. 2018 Nov 28. doi: 10.1002/ijc.32021.
    PubMed     Text format     Abstract available


  12. FENG J, Zhao F, Sun J, Lin B, et al
    Alterations in the Gut Microbiota and Metabolite Profiles of Thyroid Carcinoma Patients.
    Int J Cancer. 2018 Nov 22. doi: 10.1002/ijc.32007.
    PubMed     Text format     Abstract available


  13. KINOUCHI M, Izumi S, Nakashiro KI, Haruyama Y, et al
    Determination of the origin of oral squamous cell carcinoma by microarray analysis: Squamous epithelium or minor salivary gland?
    Int J Cancer. 2018;143:2551-2560.
    PubMed     Text format     Abstract available


  14. REN S, Gaykalova D, Wang J, Guo T, et al
    Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2018;143:2425-2436.
    PubMed     Text format     Abstract available


  15. KITAHARA CM, Preston DL, Neta G, Little MP, et al
    Occupational radiation exposure and thyroid cancer incidence in a cohort of U.S. radiologic technologists, 1983-2013.
    Int J Cancer. 2018;143:2145-2149.
    PubMed     Text format     Abstract available


    October 2018
  16. KASHIMA H, Noma K, Ohara T, Kato T, et al
    Cancer-associated fibroblasts (CAFs) promote the lymph node metastasis of esophageal squamous cell carcinoma.
    Int J Cancer. 2018 Oct 27. doi: 10.1002/ijc.31953.
    PubMed     Text format     Abstract available


  17. CUI M, Hu Y, Bi Y, Wang W, et al
    Preliminary Exploration of Potential Molecular Therapeutic Targets in Recurrent and Metastatic Parathyroid Carcinomas.
    Int J Cancer. 2018 Oct 26. doi: 10.1002/ijc.31948.
    PubMed     Text format     Abstract available


  18. HESARI A, Azizian M, Sheikh A, Nesaei A, et al
    Chemopreventive and therapeutic potential of curcumin in esophageal cancer: current and future status.
    Int J Cancer. 2018 Oct 26. doi: 10.1002/ijc.31947.
    PubMed     Text format     Abstract available


  19. SONG E, Oh HS, Jeon MJ, Chung KW, et al
    The value of preoperative anti-thyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma.
    Int J Cancer. 2018 Oct 25. doi: 10.1002/ijc.31944.
    PubMed     Text format     Abstract available


  20. JENDRZEJEWSKI J, Liyanarachchi S, Eiterman A, Thomas A, et al
    Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.
    Int J Cancer. 2018 Oct 23. doi: 10.1002/ijc.31933.
    PubMed     Text format     Abstract available


  21. HUANG FQ, Li J, Jiang L, Wang FX, et al
    Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.
    Int J Cancer. 2018 Oct 14. doi: 10.1002/ijc.31925.
    PubMed     Text format     Abstract available


    September 2018
  22. HUFBAUER M, Maltseva M, Meinrath J, Lechner A, et al
    HPV16 increases the number of migratory cancer stem cells and modulates their miRNA expression profile in oropharyngeal cancer.
    Int J Cancer. 2018;143:1426-1439.
    PubMed     Text format     Abstract available


  23. TAO Y, Sturgis EM, Huang Z, Sun Y, et al
    A TGF-beta1 genetic variant at the miRNA187 binding site significantly modifies risk of HPV16-associated oropharyngeal cancer.
    Int J Cancer. 2018;143:1327-1334.
    PubMed     Text format     Abstract available


  24. DUDDING T, Johansson M, Thomas SJ, Brennan P, et al
    Assessing the causal association between 25-hydroxyvitamin D and the risk of oral and oropharyngeal cancer using Mendelian randomization.
    Int J Cancer. 2018;143:1029-1036.
    PubMed     Text format     Abstract available


    August 2018
  25. KAUPPILA JH, Wahlin K, Lagergren P, Lagergren J, et al
    Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma.
    Int J Cancer. 2018 Aug 31. doi: 10.1002/ijc.31840.
    PubMed     Text format     Abstract available


  26. YE F, Gao H, Xiao L, Zuo Z, et al
    Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.
    Int J Cancer. 2018 Aug 22. doi: 10.1002/ijc.31825.
    PubMed     Text format     Abstract available


  27. MENYA D, Kigen N, Oduor M, Maina SK, et al
    Traditional and commercial alcohols and esophageal cancer risk in Kenya.
    Int J Cancer. 2018 Aug 17. doi: 10.1002/ijc.31804.
    PubMed     Text format     Abstract available


  28. BAO C, Pedersen NL, Yang R, Marseglia A, et al
    Diabetes in midlife and risk of cancer in late life: A nationwide Swedish twin study.
    Int J Cancer. 2018;143:793-800.
    PubMed     Text format     Abstract available


  29. ZHANG Y, Yuan Y, Wu H, Xie Z, et al
    Effect of verbascoside on apoptosis and metastasis in human oral squamous cell carcinoma.
    Int J Cancer. 2018;143:980-991.
    PubMed     Text format     Abstract available


  30. MC MENAMIN UC, Kunzmann AT, Cook MB, Johnston BT, et al
    Hormonal and reproductive factors and risk of upper gastrointestinal cancers in men: A prospective cohort study within the UK Biobank.
    Int J Cancer. 2018;143:831-841.
    PubMed     Text format     Abstract available


  31. BOON E, Bel M, van Boxtel W, van der Graaf WTA, et al
    A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.
    Int J Cancer. 2018;143:758-766.
    PubMed     Text format     Abstract available


  32. OCK S, Ahn J, Lee SH, Kim HM, et al
    Thyrocyte-specific deletion of insulin and IGF-1 receptors induces papillary thyroid carcinoma-like lesions through EGFR pathway activation.
    Int J Cancer. 2018 Aug 2. doi: 10.1002/ijc.31779.
    PubMed     Text format     Abstract available


    July 2018
  33. ROY R, Kandimalla R, Sonohara F, Koike M, et al
    A comprehensive methylation signature identifies lymph node metastasis in esophageal squamous cell carcinoma.
    Int J Cancer. 2018 Jul 14. doi: 10.1002/ijc.31755.
    PubMed     Text format     Abstract available


  34. CHEN X, Wang L, Li P, Song M, et al
    Dual TGF-beta and PD-1 blockade synergistically enhances MAGE-A3-specific CD8(+) T cell response in esophageal squamous cell carcinoma.
    Int J Cancer. 2018 Jul 7. doi: 10.1002/ijc.31730.
    PubMed     Text format     Abstract available


  35. JIANG C, Chen J, Xie S, Zhang L, et al
    Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
    Int J Cancer. 2018 Jul 4. doi: 10.1002/ijc.31642.
    PubMed     Text format     Abstract available


  36. PENG SY, Tu HF, Yang CC, Wu CH, et al
    miR-134 targets PDCD7 to reduce E-cadherin expression and enhance oral cancer progression.
    Int J Cancer. 2018 Jul 4. doi: 10.1002/ijc.31638.
    PubMed     Text format     Abstract available


  37. ABRAHAO R, Anantharaman D, Gaborieau V, Abedi-Ardekani B, et al
    The influence of smoking, age and stage at diagnosis on the survival after larynx, hypopharynx and oral cavity cancers in Europe: The ARCAGE study.
    Int J Cancer. 2018;143:32-44.
    PubMed     Text format     Abstract available


  38. SPENCE AD, Busby J, Murchie P, Kunzmann AT, et al
    Medications that relax the lower oesophageal sphincter and risk of oesophageal cancer: An analysis of two independent population-based databases.
    Int J Cancer. 2018;143:22-31.
    PubMed     Text format     Abstract available


    June 2018
  39. KO JM, Tsang KH, Dai W, Choi SSA, et al
    Leukocyte telomere length associates with nasopharyngeal carcinoma risk and survival in Hong Kong Chinese.
    Int J Cancer. 2018 Jun 6. doi: 10.1002/ijc.31617.
    PubMed     Text format     Abstract available


    May 2018
  40. BU R, Siraj AK, Divya SP, Kong Y, et al
    Telomerase reverse transcriptase mutations are independent predictor of disease-free survival in Middle Eastern papillary thyroid cancer.
    Int J Cancer. 2018;142:2028-2039.
    PubMed     Text format     Abstract available


    April 2018
  41. YU C, Guo Y, Bian Z, Yang L, et al
    Association of low-activity ALDH2 and alcohol consumption with risk of esophageal cancer in Chinese adults: A population-based cohort study.
    Int J Cancer. 2018 Apr 29. doi: 10.1002/ijc.31566.
    PubMed     Text format     Abstract available


  42. MAZUL AL, Shivappa N, Hebert JR, Steck SE, et al
    Proinflammatory diet is associated with increased risk of squamous cell head and neck cancer.
    Int J Cancer. 2018 Apr 26. doi: 10.1002/ijc.31555.
    PubMed     Text format     Abstract available


  43. DENG WW, Li YC, Ma SR, Mao L, et al
    Specific blockade CD73 alters the 'exhausted' phenotype of T cells in head and neck squamous cell carcinoma.
    Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31534.
    PubMed     Text format     Abstract available


  44. DENG WW, Li YC, Ma SR, Mao L, et al
    Specific blockade CD73 alters the 'exhausted' phenotype of T cells in head and neck squamous cell carcinoma.
    Int J Cancer. 2018 Apr 12. doi: 10.1002/ijc.31426.
    PubMed     Text format     Abstract available


  45. BEYNON RA, Lang S, Schimansky S, Penfold CM, et al
    Tobacco smoking and alcohol drinking at diagnosis of head and neck cancer and all-cause mortality: Results from Head and Neck 5000, a prospective observational cohort of people with head and neck cancer.
    Int J Cancer. 2018 Apr 1. doi: 10.1002/ijc.31416.
    PubMed     Text format    


  46. SCHROEDER L, Wichmann G, Willner M, Michel A, et al
    Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumor.
    Int J Cancer. 2018;142:1361-1368.
    PubMed     Text format     Abstract available


    March 2018
  47. ARTHUR AE, Goss AM, Demark-Wahnefried W, Mondul AM, et al
    Higher carbohydrate intake is associated with increased risk of all-cause and disease-specific mortality in head and neck cancer patients: Results from a prospective cohort study.
    Int J Cancer. 2018 Mar 31. doi: 10.1002/ijc.31413.
    PubMed     Text format     Abstract available


  48. ANNUNZIATA C, Pezzuto F, Greggi S, Ionna F, et al
    Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma.
    Int J Cancer. 2018 Mar 31. doi: 10.1002/ijc.31412.
    PubMed     Text format     Abstract available


  49. XIE SL, Fan S, Zhang SY, Chen WX, et al
    SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/beta-catenin pathway.
    Int J Cancer. 2018;142:1252-1265.
    PubMed     Text format     Abstract available


    February 2018
  50. CHUNG YL, Wu ML
    Spatiotemporal homogeneity and distinctness of the T-cell receptor beta-chain repertoires in Epstein-Barr virus-associated primary and metastatic nasopharyngeal carcinomas.
    Int J Cancer. 2018 Feb 22. doi: 10.1002/ijc.31336.
    PubMed     Text format     Abstract available


  51. TER VEER E, Creemers A, de Waal L, van Oijen MGH, et al
    Comparing cytotoxic backbones for first-line trastuzumab-containing regimens in HER2-positive advanced esophagogastric cancer: A meta-analysis.
    Int J Cancer. 2018 Feb 16. doi: 10.1002/ijc.31325.
    PubMed     Text format     Abstract available


  52. CHAN KKW, Saluja R, Delos Santos K, Lien K, et al
    Neoadjuvant Treatments for Locally Advanced, Resectable Esophageal Cancer: A Network Meta-Analysis.
    Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31312.
    PubMed     Text format     Abstract available


  53. RIETBERGEN MM, van Bokhoven AAJD, Lissenberg-Witte BI, Heideman DAM, et al
    Epidemiologic associations of HPV-positive oropharyngeal cancer and (pre)cancerous cervical lesions.
    Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31315.
    PubMed     Text format     Abstract available


    January 2018
  54. WANG YQ, Chen YP, Zhang Y, Jiang W, et al
    Prognostic significance of tumor-infiltrating lymphocytes in non-disseminated nasopharyngeal carcinoma: A large-scale cohort study.
    Int J Cancer. 2018 Jan 27. doi: 10.1002/ijc.31279.
    PubMed     Text format     Abstract available


  55. LEEMAN JE, McBride SM, Spielsinger D, Sherman EJ, et al
    Head and Neck Cancers Associated with Exposure to the September 11, 2001 World Trade Center Terrorist Attacks.
    Int J Cancer. 2018 Jan 25. doi: 10.1002/ijc.31277.
    PubMed     Text format     Abstract available


  56. MERMOD M, Hiou-Feige A, Bovay E, Roh V, et al
    Mouse model of post-surgical primary tumor recurrence and regional lymph node metastasis progression in HPV-related head and neck cancer.
    Int J Cancer. 2018 Jan 4. doi: 10.1002/ijc.31240.
    PubMed     Text format     Abstract available


    December 2017
  57. SIEW SS, Martinsen JI, Kjaerheim K, Sparen P, et al
    Occupational exposure to wood dust and risk of nasal and nasopharyngeal cancer: A case-control study among men in four nordic countries-With an emphasis on nasal adenocarcinoma.
    Int J Cancer. 2017;141:2430-2436.
    PubMed     Text format     Abstract available


  58. STANGL S, Tontcheva N, Sievert W, Shevtsov M, et al
    Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology
    Int J Cancer. 2017 Dec 13. doi: 10.1002/ijc.31213.
    PubMed     Text format     Abstract available


  59. ANDERSON C, Engel SM, Weaver MA, Zevallos JP, et al
    Birth rates after radioactive iodine treatment for differentiated thyroid cancer.
    Int J Cancer. 2017;141:2291-2295.
    PubMed     Text format     Abstract available


  60. BERANIA I, Cardin GB, Clement I, Guertin L, et al
    Four PTEN-targeting co-expressed miRNAs and ACTN4- targeting miR-548b are independent prognostic biomarkers in human squamous cell carcinoma of the oral tongue.
    Int J Cancer. 2017;141:2318-2328.
    PubMed     Text format     Abstract available


    November 2017
  61. DOSSUS L, Franceschi S, Biessy C, Navionis AS, et al
    Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study.
    Int J Cancer. 2017 Nov 23. doi: 10.1002/ijc.31172.
    PubMed     Text format     Abstract available


  62. YUNHONG T, Jie L, Yunming T, Guoqian Z, et al
    Efficacy and safety of anti-EGFR agents administered concurrently with standard therapies for patients with head and neck squamous cell carcinoma: A systematic review and meta-analysis of randomized controlled trials.
    Int J Cancer. 2017 Nov 16. doi: 10.1002/ijc.31157.
    PubMed     Text format     Abstract available


  63. RAJENDRA S, Yang T, Xuan W, Sharma P, et al
    Active human papillomavirus involvement in Barrett's dysplasia and oesophageal adenocarcinoma is characterized by wild-type p53 and aberrations of the retinoblastoma protein pathway.
    Int J Cancer. 2017;141:2037-2049.
    PubMed     Text format     Abstract available


  64. HU J, Li H, Luo X, Li Y, et al
    The role of oxidative stress in EBV lytic reactivation, radioresistance and the potential preventive and therapeutic implications.
    Int J Cancer. 2017;141:1722-1729.
    PubMed     Text format     Abstract available


    October 2017
  65. MAO L, Zhao ZL, Yu GT, Wu L, et al
    gamma-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma.
    Int J Cancer. 2017 Oct 19. doi: 10.1002/ijc.31115.
    PubMed     Text format     Abstract available


  66. HOFFMANN M, Pasch S, Schamberger T, Maneck M, et al
    Diagnostic pathology of early systemic cancer: ERBB2 gene amplification in single disseminated cancer cells determines patient survival in operable esophageal cancer.
    Int J Cancer. 2017 Oct 16. doi: 10.1002/ijc.31108.
    PubMed     Text format     Abstract available


  67. TRONKO M, Brenner AV, Bogdanova T, Shpak V, et al
    Thyroid neoplasia risk is increased nearly 30 years after the Chernobyl accident.
    Int J Cancer. 2017;141:1585-1588.
    PubMed     Text format     Abstract available


  68. ZHU L, Sturgis EM, Zhang H, Lu Z, et al
    Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.
    Int J Cancer. 2017;141:1355-1364.
    PubMed     Text format     Abstract available


  69. PAN R, Zhu M, Yu C, Lv J, et al
    Cancer incidence and mortality: A cohort study in China, 2008-2013.
    Int J Cancer. 2017;141:1315-1323.
    PubMed     Text format     Abstract available


    September 2017
  70. KLINGHAMMER K, Keller J, George J, Hoffmann J, et al
    A phosphoarray platform is capable of personalizing kinase inhibitor therapy in head and neck cancers.
    Int J Cancer. 2017 Sep 14. doi: 10.1002/ijc.31045.
    PubMed     Text format     Abstract available


  71. LIU J, Lv L, Gong J, Tan Y, et al
    Overexpression of F-box only protein 31 predicts poor prognosis and deregulates p38alpha- and JNK-mediated apoptosis in esophageal squamous cell carcinoma.
    Int J Cancer. 2017 Sep 14. doi: 10.1002/ijc.31040.
    PubMed     Text format     Abstract available


    August 2017
  72. FOUNTZILAS G, Psyrri A, Giannoulatou E, Tikas I, et al
    Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe.
    Int J Cancer. 2017 Aug 31. doi: 10.1002/ijc.31023.
    PubMed     Text format     Abstract available


  73. TWAROCK S, Reichert C, Peters U, Gorski DJ, et al
    Hyperglycaemia and aberrated insulin signalling stimulate tumour progression via induction of the extracellular matrix component hyaluronan.
    Int J Cancer. 2017;141:791-804.
    PubMed     Text format     Abstract available


  74. SHIVAPPA N, Hebert JR, Rosato V, Garavello W, et al
    Inflammatory potential of diet and risk of oral and pharyngeal cancer in a large case-control study from Italy.
    Int J Cancer. 2017;141:471-479.
    PubMed     Text format     Abstract available


    July 2017
  75. WANG YK, Chuang YS, Wu TS, Lee KW, et al
    Endoscopic screening for synchronous esophageal neoplasia among patients with incident head and neck cancer: Prevalence, risk factors and outcomes.
    Int J Cancer. 2017 Jul 30. doi: 10.1002/ijc.30911.
    PubMed     Text format     Abstract available


  76. KAWAKITA D, Amy Lee YC, Turati F, Parpinel M, et al
    Dietary fiber intake and head and neck cancer risk: A pooled analysis in the International Head and Neck Cancer Epidemiology consortium.
    Int J Cancer. 2017 Jul 14. doi: 10.1002/ijc.30886.
    PubMed     Text format     Abstract available


  77. ZAMORA-ROS R, Beraud V, Franceschi S, Cayssials V, et al
    Consumption of fruits, vegetables, and fruit juices and differentiated thyroid carcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
    Int J Cancer. 2017 Jul 8. doi: 10.1002/ijc.30880.
    PubMed     Text format     Abstract available


    June 2017
  78. HOLZINGER D, Wichmann G, Baboci L, Michel A, et al
    Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2017;140:2748-2757.
    PubMed     Text format     Abstract available


  79. BOSCOLO-RIZZO P, Dietz A
    The AJCC/UICC eighth edition for staging head and neck cancers: Is it wise to de-escalate treatment regimens in p16-positive oropharyngeal cancer patients?
    Int J Cancer. 2017 Jun 14. doi: 10.1002/ijc.30837.
    PubMed     Text format    


  80. YOU R, Sun R, Hua YJ, Li CF, et al
    Cetuximab or Nimotuzumab plus Intensity-modulated Radiotherapy Versus Cisplatin plus Intensity-modulated Radiotherapy for Stage II-IVb Nasopharyngeal Carcinoma.
    Int J Cancer. 2017 Jun 2. doi: 10.1002/ijc.30819.
    PubMed     Text format     Abstract available


  81. MILLRUD CR, Kagedal A, Kumlien Georen S, Winqvist O, et al
    NET-producing CD16high CD62Ldim neutrophils migrate to tumor sites and predict improved survival in patients with HNSCC.
    Int J Cancer. 2017;140:2557-2567.
    PubMed     Text format     Abstract available


    May 2017
  82. MIRANTI EH, Stolzenberg-Solomon R, Weinstein SJ, Selhub J, et al
    Low Vitamin B12 Increases Risk of Gastric Cancer: A Prospective Study of One-Carbon Metabolism Nutrients and Risk of Upper Gastrointestinal Tract Cancer.
    Int J Cancer. 2017 May 31. doi: 10.1002/ijc.30809.
    PubMed     Text format     Abstract available


  83. KLINGHAMMER K, Otto R, Raguse JD, Albers AE, et al
    Basal subtype is predictive for response to cetuximab treatment in patient derived xenografts of squamous cell head and neck cancer.
    Int J Cancer. 2017 May 30. doi: 10.1002/ijc.30808.
    PubMed     Text format     Abstract available


  84. CARIOLI G, Negri E, Kawakita D, Garavello W, et al
    Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: Focus on low-risk areas.
    Int J Cancer. 2017;140:2256-2264.
    PubMed     Text format     Abstract available


  85. BALERMPAS P, Rodel F, Krause M, Linge A, et al
    The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Int J Cancer. 2017 May 8. doi: 10.1002/ijc.30770.
    PubMed     Text format     Abstract available


  86. MEYERS TJ, Chang SC, Chang PY, Morgenstern H, et al
    Case-control study of cumulative cigarette tar exposure and lung and upper aerodigestive tract cancers.
    Int J Cancer. 2017;140:2040-2050.
    PubMed     Text format     Abstract available


  87. SPROLL C, Freund AK, Hassel A, Holbling M, et al
    Immunohistochemical detection of lymph node-DTCs in patients with node-negative HNSCC.
    Int J Cancer. 2017;140:2112-2124.
    PubMed     Text format     Abstract available


    April 2017
  88. RENKONEN S, Lee M, Makitie A, Lindstrom LS, et al
    Site-specific familial risk and survival of familial and sporadic head and neck cancer.
    Int J Cancer. 2017 Apr 25. doi: 10.1002/ijc.30751.
    PubMed     Text format     Abstract available


  89. LU Z, Zhang C, Sheng J, Shen J, et al
    T cell receptor beta-chain repertoire analysis reveals the association between neoantigens and tumour-infiltrating lymphocytes in multifocal papillary thyroid carcinoma.
    Int J Cancer. 2017 Apr 21. doi: 10.1002/ijc.30743.
    PubMed     Text format     Abstract available


  90. BUSBY J, Murchie P, Murray L, Iversen L, et al
    The effect of medications which cause inflammation of the gastro-oesophageal tract on cancer risk: a nested case-control study of routine Scottish data.
    Int J Cancer. 2017;140:1828-1835.
    PubMed     Text format     Abstract available


  91. FRANK C, Sundquist J, Yu H, Hemminki A, et al
    Concordant and discordant familial cancer: Familial risks, proportions and population impact.
    Int J Cancer. 2017;140:1510-1516.
    PubMed     Text format     Abstract available


  92. LEVINGSTON CA, Young MR
    Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD-1 antibodies.
    Int J Cancer. 2017;140:1609-1619.
    PubMed     Text format     Abstract available


  93. DE MARTEL C, Plummer M, Vignat J, Franceschi S, et al
    Worldwide burden of cancer attributable to HPV by site, country and HPV type.
    Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30716.
    PubMed     Text format     Abstract available


    March 2017
  94. GHEIT T, Anantharaman D, Holzinger D, Alemany L, et al
    Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India.
    Int J Cancer. 2017 Mar 29. doi: 10.1002/ijc.30712.
    PubMed     Text format     Abstract available


  95. CHEOL PARK G, Roh JL, Cho KJ, Seung Kim J, et al
    18 F-FDG PET/CT vs. human papillomavirus, p16 and Epstein-Barr virus detection in cervical metastatic lymph nodes for identifying primary tumors.
    Int J Cancer. 2017;140:1405-1412.
    PubMed     Text format     Abstract available


  96. PRIGGE ES, Arbyn M, von Knebel Doeberitz M, Reuschenbach M, et al
    Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.
    Int J Cancer. 2017;140:1186-1198.
    PubMed     Text format     Abstract available


  97. SCHNELLE C, Whiteman DC, Porceddu SV, Panizza BJ, et al
    Past sexual behaviors and risks of oropharyngeal squamous cell carcinoma: a case-case comparison.
    Int J Cancer. 2017;140:1027-1034.
    PubMed     Text format     Abstract available


    February 2017
  98. LIEDERBACH E, Kyrillos A, Wang CH, Liu JC, et al
    The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma.
    Int J Cancer. 2017;140:504-512.
    PubMed     Text format     Abstract available


    January 2017
  99. FALCONER H, Yin L, Bellocco R, Altman D, et al
    Thyroid cancer after hysterectomy on benign indications: Findings from an observational cohort study in Sweden.
    Int J Cancer. 2017 Jan 19. doi: 10.1002/ijc.30606.
    PubMed     Text format     Abstract available


  100. MCCORMACK VA, Menya D, Munishi MO, Dzamalala C, et al
    Informing etiologic research priorities for squamous cell esophageal cancer in Africa: A review of setting-specific exposures to known and putative risk factors.
    Int J Cancer. 2017;140:259-271.
    PubMed     Text format     Abstract available


  101. KANEMARU A, Yamamoto K, Kawaguchi M, Fukushima T, et al
    Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer-associated fibroblasts by paracrine activation of protease-activated receptor 2.
    Int J Cancer. 2017;140:130-141.
    PubMed     Text format     Abstract available


    December 2016
  102. BRUSSELAERS N, Maret-Ouda J, Konings P, El-Serag HB, et al
    Menopausal hormone therapy and the risk of esophageal and gastric cancer.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30588.
    PubMed     Text format     Abstract available


  103. PIETRANTONIO F, Caporale M, Morano F, Scartozzi M, et al
    HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research.
    Int J Cancer. 2016;139:2859-2864.
    PubMed     Text format     Abstract available


    September 2016
  104. OGHUMU S, Knobloch TJ, Terrazas C, Varikuti S, et al
    Deletion of macrophage migration inhibitory factor inhibits murine oral carcinogenesis: Potential role for chronic pro-inflammatory immune mediators.
    Int J Cancer. 2016;139:1379-90.
    PubMed     Text format     Abstract available


    August 2016
  105. GARNAES E, Frederiksen K, Kiss K, Andersen L, et al
    Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study.
    Int J Cancer. 2016 Aug 18. doi: 10.1002/ijc.30389.
    PubMed     Text format     Abstract available


  106. VAN DIJK BA, Brands MT, Geurts SM, Merkx MA, et al
    Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands.
    Int J Cancer. 2016;139:574-83.
    PubMed     Text format     Abstract available


    July 2016
  107. GUO T, Gaykalova DA, Considine M, Wheelan S, et al
    Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2016;139:373-82.
    PubMed     Text format     Abstract available


  108. AL-HEBSHI NN, Li S, Nasher AT, El-Setouhy M, et al
    Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes.
    Int J Cancer. 2016;139:363-72.
    PubMed     Text format     Abstract available


    June 2016
  109. BODELON C, Untereiner ME, Machiela MJ, Vinokurova S, et al
    Genomic characterization of viral integration sites in HPV-related cancers.
    Int J Cancer. 2016 Jun 25. doi: 10.1002/ijc.30243.
    PubMed     Text format     Abstract available


    February 2016
  110. BROTHERTON JM, Jit M, Gravitt PE, Brisson M, et al
    Eurogin Roadmap 2015: How has HPV knowledge changed our practice: vaccines.
    Int J Cancer. 2016 Feb 24. doi: 10.1002/ijc.30063.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: